Abstract
Many factors influence drug activity in brain. One of the most important is the ability of a drug to gain access to brain following systemic administration by passage across the blood-brain barrier (BBB). The BBB is formed at the cerebral capillaries by a continuous layer of endothelial cells that are joined together by high resistance tight junctions (Pardridge, 1998). These tight junctions effectively seal off the aqueous paracellular channels between brain endothelial cells, so that if a drug is to gain access to brain it must either be of the appropriate lipid solubility, hydrogen bonding capacity, and size to readily dissolve and diffuse across the lipophilic endothelial cell membranes (Habgood et al.,2000) or be transported across the endothelium by any of 20 or more active or facilitated carrier systems which are expressed in brain capillaries at high levels (Smith et al.,1995).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Deane, R. and Bradbury, M.W.B., 1990, Transport of lead-203 at the blood-brain barrier during short cerebrovascular perfusion with saline in the rat. J Neurochem 54: 905–914.
Dubey, R.K., McAllister, C.B., Inoue, M., and Wilkinson, G.R., 1989, Plasma binding and transport of diazepam across the blood-brain barrier: no evidence for in vivo enhanced dissociation. J. Clin. Invest. 84: 1155–1159.
Fenerty, C.A., and Lindup, W.E., 1989, Brain uptake of L-tryptophan and diazepam: the role of plasma protein binding. J. Neurochem. 53: 416–422.
Fukui, S., Schwarcz, R., Rapoport, S.I., Takada, Y., and Smith, Q.R., 1991, Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J. Neurochem. 56: 2007–2017.
Habgood, M.D., Begley, D.J., and Abbott, N.J., 2000, Determinants of passive drug entry into the central nervous system. Cell. Mol. Neurobiol. 20: 231–253.
Hansch, C., and Leo, A., 1995, Exploring QSAR. American Chemical Society, Washington, D.C.
Ives, N.K., and Gardiner, R.M., 1990, Blood-brain barrier permeability to bilirubin in the rat studied using intracarotid bolus injection and in situ brain perfusion techniques. Pediatr. Res. 27: 436–441.
Jezequel, S.G., 1992, Central nervous system penetration of drugs: importance of physicochemical properties. In Progress in Drug Metabolism (G.G. Gibson, ed.); Taylor and Francis, London, pp. 141–178.
Jones, D.R., Hall, S.D., Jackson, E.K., Branch, R.A., and Wilkinson, G.R., 1988, Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein binding. JPET 245: 816–822.
Kragh-Hansen, U., 1981, Molecular aspects of ligand binding to serum albumin. Pharm. Rev. 33: 17–53.
Levitan, H., Ziylan, Z., Smith, Q.R., Takasato, Y., and Rapoport, S.I., 1984, Brain uptake of a food dye, erythrosin B, prevented by plasma protein binding. Brain Res. 322: 131–134.
Lin, T-H., and Lin, J.H., 1990, Effects of protein binding and experimental disease states on brain uptake of benzodiazepines in rats. JPET 253: 45–50.
Morris, C.A., Keith, A.B., Edwardson, J.A., and Pullen, R.G.L., 1992, Uptake and distribution of iron and transferrin in the adult rat brain. J. Neurochem. 59: 300–306.
Murphy, V.A., and Rapoport, S.I., 1992, Brain transfer coefficients for 67Ga: comparison to 55Fe and effect of calcium deficiency. J. Neurochem. 58: 898–902.
Pardridge, W.M., 1998, CNS drug design based on principles of blood-brain barrier transport. J. Neurochem. 70: 1781–1792..
Pardridge, W.M., Eisenberg, J., and Cefalu, W.T., 1985, Absence of albumin receptor on brain capillaries in vivo or in vitro. Am. J. Physiol. 249: E264–E267.
Pardridge, W.M., and Landaw, E.M., 1984, Tracer kinetic model of blood-brain barrier transport of plasma protein-bound ligands. J. Clin. Invest. 74: 745–752.
Pardridge W.M. and Mietus, L.J., 1980, Palmitate and cholesterol transport through the blood-brain barrier. J. Neurochem. 34: 463–466.
Peters, T., 1996, All about albumin: biochemistry, genetics, and medical applications. Academic Press, San Diego.
Rabin, O., Hegedus, L., Bourre, J-M., and Smith, Q.R., 1993, Rapid brain uptake of manganese (II) across the blood-brain barrier. J. Neurochem. 61: 509–517.
Robinson P.J., Noronha, J., DeGeorge J J., Freed L.M., Nariai T., and Rapoport, S.I., 1992, A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res. Rev. 17: 187–214.
Robinson, P.J., and Rapoport, S.I., 1986, Kinetics of protein binding determine rates of uptake of drugs by brain. Am. J. Physiol. 251: R1212–R1220.
Smith, Q.R., 1995, Carrier-mediated drug transport at the blood-brain barrier and the potential for drug targeting to the brain. In New Concepts of a Blood-Brain Barrier (J. Greenwood, et. al., eds.); Plenum Press, New York, pp. 265–276.
Smith Q. R., 1996, Brain perfusion systems for studies of drug uptake and metabolism in the central nervous system. Pharmaceut. Biotech. 8: 285–308.
Smith, Q.R., and Nagura, H., 2001, Fatty acid uptake and incorporation in brain. J. Mol. Neurosci. 16: 81–86.
Smith, Q.R., Fisher, C., Allen, D., and Oki, J.: Development of a novel screening method to predict brain availability to drugs that bind highly to plasma proteins. Pharm. Sci. (Supplement) 1: 3115, 1998.
Smith, Q.R., Fisher, C.R., and Liu, X.: Brain uptake of the lipophilic anticancer drug chlorambucil-Limitation by plasma protein binding. Pharm. Sci. (Supplement) 2: 2106, 200
Spector, R., 1988, Fatty acid transport through the blood-brain barrier. J. Neurochem. 50: 639–643.
Svenson, A., Holmer, E., and Andersson, L-O., 1974, A new method for the measurement of dissociation rates for complexes between small ligands and proteins as applied to the palmitate and bilirubin complexes with serum albumin. BBA 342: 54–59.
Takasato, Y., Rapoport, S.I., and Smith, Q.R., 1984, An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am. J. Physiol. 246: H484–H493.
Tanaka, H., and Mizojiri, K., 1999, Drug-protein binding and blood-brain barrier permeability. J. Pharmacol. Exp. Ther. 288: 912–918.
Tillement, J-P., Houin, G., Zini, R., Urien, S., Albengres, E., Barre, J., Lecomte, M., D’Athis, P., and Sebille, B., 1984, The binding of drugs to blood plasma macromolecules: recent advances and therapeutic significance. In Advances in Drug Research 13: 60–94.
Wosilait, W. D., and Soler-Argilaga, C., 1975, A theoretical analysis of the multiple binding of palmitate by bovine serum albumin: the relationship to uptake of free fatty acids by tissues. Life Sci. 17: 159–166.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Smith, Q.R., Fisher, C., Allen, D.D. (2001). The Role of Plasma Protein Binding in Drug Delivery to Brain. In: Kobiler, D., Lustig, S., Shapira, S. (eds) Blood—Brain Barrier. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0579-2_25
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0579-2_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5141-2
Online ISBN: 978-1-4615-0579-2
eBook Packages: Springer Book Archive